Results 101 to 110 of about 2,856,278 (190)

Alzheimer's Disease: Mechanisms and Therapeutic Advances

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu   +4 more
wiley   +1 more source

Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis from 2010 to 2013 in Korea.

open access: yes, 2016
Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis from 2010 to 2013 in Korea.
Jayeun Kim (3344228)   +9 more
core   +1 more source

Signs of compliance: Message framing influences outdoor recreationists' responses to conservation requests

open access: yesPeople and Nature, Volume 8, Issue 11, Page 4091-4104, November 2026.
Abstract Natural landscapes shared by people and wildlife often rely on signage to guide people towards behaviours that protect nature, where the justification and framing of these requests may influence how people interpret and respond to them. We conducted a factorial vignette experiment with 600 frequent outdoor recreationists living in Scotland ...
Amber Cowans   +4 more
wiley   +1 more source

Risk of Stevens-Johnson Syndrome with AED Therapy

open access: yes, 1999
The role of antiepileptic drugs in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) was evaluated in a case-control study in Europe and reported from Mannheim ...
J Gordon Millichap, Millichap, J. Gordon
core   +1 more source

Phenytoin-induced Stevens–Johnson syndrome with myocarditis: a rare case report

open access: yes, 2017
Ashwin Kodliwadmath Department of Medicine, Belgaum Institute of Medical Sciences, Belgaum, India Abstract: Stevens–Johnson syndrome (SJS) is an acute life-threatening mucocutaneous reaction caused by excessive necrosis and detachment of the ...
Kodliwadmath A
core  

Putative lotilaner/milbemycin‐induced Stevens‐Johnson syndrome/toxic epidermal necrolysis in a dog

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Abstract Stevens‒Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe skin and mucocutaneous reaction, characterised by extensive epidermal necrosis and skin sloughing. Drugs are common triggers, with reactions to a number of classes reported.
Matt McHale   +3 more
wiley   +1 more source

Chlordiazepoxide induced Stevens-Johnson syndrome in acute pancreatitis [PDF]

open access: yes, 2017
Stevens-Johnson Syndrome (SJS) is an acute hypersensitive reaction and a life-threatening condition affecting both skin and mucous membranes. We report a case with SJS likely induced by Chlordiazepoxide.
Yerramaneni, Rakesh   +4 more
core   +1 more source

Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study

open access: yesAustralasian Journal of Dermatology, Volume 67, Issue 7, Page e431-e435, November 2026.
ABSTRACT This Australian retrospective cohort analysis of 1977 patients investigates and expands on correlates of telangiectasia in systemic sclerosis to determine whether this cutaneous sign is a potential surrogate marker for disease progression and prognosis.
Vivien Wai Yun Lai   +15 more
wiley   +1 more source

Stevens Johnson syndrome secondary to Phenobarbitone

open access: yes, 2012
This paper has Been Presented for Promotion at the University of KhartoumStevens-Johnson syndrome (SJS) is a severe cutaneous eruption that most often appears as an adverse reaction to medication.
Abdelmoneim E.M. Kheir
core  

Dermatologic Toxicities Associated With Novel Pan‐RAS/RAF Inhibitors

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 11, Page 1042-1050, November 2026.
ABSTRACT Background The mitogen‐activated protein kinase (MAPK) pathway plays a key role in cell‐cycle regulation and tumor progression in cancer. Dermatologic toxicities (DTs) to newer pan‐RAS (RMC‐6236) and pan‐RAF (LXH254/naporafenib) inhibitors are emerging.
Lin J. He   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy